www.antimicrobe.org

[Start Page] [Microbes] [Antimicrobial Agents] [HIV Clinical Manual] [Feedback] [Logout]

Borrelia burgdorferi (Lyme Disease)

Read the Chapter

Sliding Table of Contents on the left of the screen

 

Tables and Figures

Table 1:  Antimicrobial Treatment of Lyme Disease [Download PDF]

Figure 1: Erythema multiforme with central clearing originating in the submammary fold. Often there is a central area of erythema remaining at the site of the tick bite (punctum). Although this is the “classical” presentation of erythema migrans, it is not the most common (See Figures 2 and 3).

Figure 2: Erythema migrans with homogenous erythema (and lack of central clearing). Note that this is the most common presentation of erythema migrans in the U.S.

Figure 3: Erythema migrans rash without central clearing. Note the easily observed central punctum (arrow) at the site of tick bite.

Figure 4: Vesicular rash surround by erythema occurring over the knee. This lesion was thought to represent a spider bite reaction and the patient was treated with cephalexin without response. Borrelia burgdorferi was isolated by culture of a skin biopsy of the leading margin of erythema.

 

Video

Video: Borrelia burgdorferi. Provided by CytoViva.

 

Vignettes

Guideline:  Halperin JJ, et al.  Practice Parameter: Treatment of Nervous System Lyme Disease (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology (Endorsed by IDSA).  Neurology 2007;69:91-102.

Review Article: Auwaerter PG. Point: Antibiotic Therapy Is Not the Answer for Patients with Persisting Symptoms Attributable to Lyme Disease.  Clin Infect Dis 2007;45:143-148.

Review Article: Stricker RB. Counterpoint: Long-Term Antibiotic Therapy Improved Persistent Symptoms Associated with Lyme Disease.  Clin Infect Dis 2007;45:149-157.

Dixon B.  Lyme Disease -- The Public Dimension.  Microbe 2007;2:114-115.

Berger S.  Emergence of Infectious Diseases into the 21st Century, 2008.

Vazquez M, Muehlenbein C, et al. Effectiveness of Personal Protective Measures to Prevent Lyme Disease.  Emerg Infect Dis 2008;14(2):210-216.

Steere AC et al. Prospective Study of Serologic Tests for Lyme Disease. Clin Infect Dis. 2008 Jul 15;47(2):188-95

Hingwe, A Jarisch-Herxheimer reaction. 2009

Authors

Eugene D. Shapiro, M.D.Paul Auwaerter, M.D.

 

Previous author: David L. Coleman, M.D., 1997 Edition, 2002 Edition

 

 

 

www.antimicrobe.org

[Start Page] [Microbes] [Antimicrobial Agents] [HIV Clinical Manual] [Feedback] [Logout]